NHI
National Health Investors, Inc.
NYSEUSDEQUITY
Real Estate
DELAYED
Sell
-37/100
Last price
65.54
▲ 0.52 (0.80%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
65.15
Prev close
65.02
Day high
65.60
Day low
64.51
Volume
432.48K
Market cap
$3.22B
P/E (TTM)
18.78
52W range
64.51 – 91.38
Day trading desk
Gap from prior close
+0.20%
Prior close 65.02
VWAP
65.39
+0.22% from price
Relative volume
1.92×
Unusually busy
Session range
1.69%
64.51 – 65.60
Position in range
94%
Near session high
ATR (14D)
1.21
1.85% of price
Prior day high
65.86
PDH
Prior day low
64.95
PDL
Bid / ask spread
—
Quote not published
Session volume
729.24K
Avg 378.91K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.68%
-3.6%
1M
-7.53%
-8.7%
3M
-14.52%
-19.0%
6M
-22.31%
-40.5%
YTD
-14.18%
-28.4%
1Y
-16.50%
-32.9%
3Y
+27.61%
-54.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on NHI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.18M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 15, 26 | MCCABE ROBERT A. JR. Director |
BUY | 890 | $63.77K | Direct |
| Jun 5, 26 | JOBE JAMES R Director |
STOCK | 225 | $0 | Direct |
| Jun 5, 26 | MENDELSOHN D ERIC Chief Executive Officer |
BUY | 1.50K | $103.26K | Direct |
| Mar 3, 26 | MCCABE ROBERT A. JR. Director |
STOCK | 1.27K | $0 | Direct |
| Mar 3, 26 | COLDEN TRACY M J Director |
STOCK | 1.27K | $0 | Direct |
| Mar 3, 26 | CHAPIN ROBERT JR. Director |
STOCK | 1.27K | $0 | Direct |
| Mar 3, 26 | JOBE JAMES R Director |
STOCK | 1.27K | $0 | Direct |
| Mar 3, 26 | MENDELSOHN D ERIC Chief Executive Officer |
STOCK | 14.41K | $0 | Direct |
| Mar 3, 26 | PASCOE KEVIN CARLTON Chief Investment Officer |
STOCK | 5.07K | $0 | Direct |
| Mar 3, 26 | PASCOE KEVIN CARLTON Chief Investment Officer |
STOCK | 4.73K | $0 | Direct |
| Mar 3, 26 | SPAID JOHN L Officer |
STOCK | 5.07K | $0 | Direct |
| Mar 3, 26 | SPAID JOHN L Officer |
CONVERSION | 15.00K | $1.10M | Direct |
| Mar 3, 26 | TRAVIS DAVID L Officer |
STOCK | 3.46K | $0 | Direct |
| Mar 3, 26 | TODD CANDICE W. Director |
STOCK | 1.27K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ADAMS ROBERT G. |
Director | — | Conversion of Exercise of derivative security |
COLDEN TRACY M J |
Director | 12.86K | Stock Award(Grant) |
GAINES KRISTIN SALLEE |
Officer | 73.76K | Conversion of Exercise of derivative security |
JOBE JAMES R |
Director | 35.04K | Stock Gift |
MCCABE ROBERT A. JR. |
Director | 44.16K | Purchase |
MENDELSOHN D ERIC |
Chief Executive Officer | 133.32K | Purchase |
PASCOE KEVIN CARLTON |
Chief Investment Officer | 73.43K | Stock Award(Grant) |
SPAID JOHN L |
Officer | 56.25K | Stock Award(Grant) |
SWAFFORD CHARLOTTE A |
Director | — | Conversion of Exercise of derivative security |
TRAVIS DAVID L |
Officer | 40.85K | Stock Award(Grant) |
Fundamentals
Market cap$3.22B
Enterprise value$4.48B
Revenue (TTM)$435.78M
Gross profit$322.15M
EBITDA$289.67M
Net income$166.52M
EPS (TTM)$3.49
Free cash flow$171.98M
Total cash$30.39M
Total debt$1.28B
Book value / share$31.99
Shares outstanding49.11M
Float47.94M
Short % of float4.19%
Dividend yield5.74%
Beta (5Y)0.52
Valuation & profitability ratios
Trailing P/E18.78
Forward P/E20.19
PEG ratio4.76
Price / sales—
Price / book2.05
EV / revenue10.29
EV / EBITDA15.48
Gross margin73.92%
Operating margin41.09%
Profit margin38.27%
Return on equity10.72%
Return on assets4.38%
Debt / equity80.43
Current ratio1.82
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $375.63M | $335.18M | $319.83M | $278.19M | +12.1% |
| Operating revenue | $375.63M | $335.18M | $319.83M | $278.19M | +12.1% |
| Cost of revenue | $10.98M | $11.16M | $11.51M | $9.79M | -1.6% |
| Gross profit | $364.65M | $324.02M | $308.32M | $268.41M | +12.5% |
| Selling, general & admin | $29.53M | $21.79M | $19.82M | $25.32M | +35.6% |
| Total operating expense | $174.06M | $135.52M | $129.83M | $135.64M | +28.4% |
| Operating income | $190.59M | $188.50M | $178.49M | $132.77M | +1.1% |
| Net interest income | -$57.37M | -$59.90M | -$58.16M | -$44.92M | +4.2% |
| Pre-tax income | $140.79M | $136.64M | $134.38M | $65.41M | +3.0% |
| Net income | $142.18M | $137.99M | $135.65M | $66.40M | +3.0% |
| Net income to common | $141.98M | $137.87M | $135.60M | $66.40M | +3.0% |
| Basic EPS | 3.03 | 3.14 | 3.13 | 1.48 | -3.5% |
| Diluted EPS | 3.02 | 3.13 | 3.13 | 1.48 | -3.5% |
| EBIT | $194.73M | $192.76M | $189.89M | $107.85M | +1.0% |
| EBITDA | $275.67M | $264.20M | $259.87M | $178.73M | +4.3% |
| Basic shares | 46.87M | 43.84M | 43.39M | 44.77M | +6.9% |
| Diluted shares | 47.05M | 44.10M | 43.39M | 44.79M | +6.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $19.62M | $24.29M | $22.35M | $19.29M | -19.2% |
| Cash & short-term investments | $19.62M | $24.29M | $22.35M | $19.29M | -19.2% |
| Accounts receivable | $85.46M | $93.61M | $89.63M | $81.86M | -8.7% |
| Total current assets | $316.92M | $396.91M | $375.19M | $383.01M | -20.2% |
| Total assets | $2.80B | $2.61B | $2.49B | $2.51B | +7.0% |
| Total current liabilities | $297.17M | $414.35M | $324.38M | $112.01M | -28.3% |
| Current debt | $204.00M | $331.20M | $245.00M | $42.00M | -38.4% |
| Long-term debt | $959.81M | $814.84M | $890.05M | $1.11B | +17.8% |
| Total debt | $1.16B | $1.15B | $1.14B | $1.15B | +1.6% |
| Total liabilities | $1.26B | $1.23B | $1.21B | $1.22B | +2.3% |
| Retained earnings | $2.75B | $2.60B | $2.47B | $2.33B | +5.5% |
| Shareholder equity | $1.52B | $1.37B | $1.25B | $1.27B | +11.3% |
| Working capital | $19.75M | -$17.44M | $50.81M | $271.00M | +213.2% |
| Net tangible assets | $1.52B | $1.37B | $1.25B | $1.27B | +11.3% |
| Shares issued | 48.30M | 45.69M | 43.41M | 43.39M | +5.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $140.79M | $136.64M | $134.38M | $65.50M | — | +3.0% |
| Depreciation & amortisation | $80.94M | $71.44M | $69.97M | $70.88M | — | +13.3% |
| Stock-based compensation | $5.58M | $4.18M | $4.61M | $8.61M | — | +33.3% |
| Change in working capital | $7.26M | $245.00K | $5.33M | -$2.70M | — | +2,863.3% |
| Operating cash flow | $236.56M | $207.77M | $184.45M | $185.34M | — | +13.9% |
| Capital expenditure | — | -$4.07M | -$3.74M | — | -$64.00K | — |
| Investing cash flow | -$269.15M | -$192.31M | -$11.63M | $197.94M | — | -40.0% |
| Share buybacks | — | $0 | $0 | -$151.95M | $0 | — |
| Dividends paid | -$169.70M | -$156.51M | -$156.24M | -$161.77M | — | -8.4% |
| Financing cash flow | $25.71M | -$13.57M | -$169.72M | -$401.25M | — | +289.5% |
| Free cash flow | $236.56M | $207.77M | $184.45M | $185.34M | — | +13.9% |
| End cash position | $19.62M | $26.50M | $24.62M | $21.52M | — | -26.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $121.32M | $115.13M | $105.82M | $89.85M | $90.66M | +5.4% |
| Operating revenue | $121.32M | $115.13M | $105.82M | $89.85M | $90.66M | +5.4% |
| Cost of revenue | $2.74M | $2.80M | $2.57M | $2.61M | $2.91M | -2.2% |
| Gross profit | $118.58M | $112.33M | $103.25M | $87.24M | $87.75M | +5.6% |
| Selling, general & admin | $9.27M | $8.16M | $7.61M | $6.45M | $7.22M | +13.6% |
| Total operating expense | $68.79M | $60.23M | $53.02M | $43.16M | $39.09M | +14.2% |
| Operating income | $49.79M | $52.09M | $50.23M | $44.08M | $48.66M | -4.4% |
| Net interest income | -$15.81M | -$15.04M | -$14.26M | -$13.77M | -$15.00M | -5.1% |
| Pre-tax income | $56.09M | $39.75M | $37.80M | $32.48M | $36.69M | +41.1% |
| Tax provision | $732.00K | — | — | — | $0 | — |
| Net income | $55.67M | $40.10M | $38.16M | $32.86M | $36.99M | +38.8% |
| Net income to common | $55.58M | $40.02M | $38.11M | $32.81M | $36.94M | +38.9% |
| Basic EPS | 1.15 | 0.83 | 0.80 | 0.69 | 0.79 | +38.6% |
| Diluted EPS | 1.15 | 0.82 | 0.80 | 0.69 | 0.79 | +40.2% |
| EBIT | $71.05M | $53.94M | $51.22M | $45.59M | $50.75M | +31.7% |
| EBITDA | $96.60M | $77.63M | $72.87M | $65.80M | $70.67M | +24.4% |
| Basic shares | 48.44M | 48.32M | 47.65M | 47.43M | 46.69M | +0.2% |
| Diluted shares | 48.50M | 48.55M | 47.88M | 47.62M | 46.82M | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.39M | $24.95M | $19.62M | $81.63M | $18.64M | +21.8% |
| Cash & short-term investments | $30.39M | $24.95M | $19.62M | $81.63M | $18.64M | +21.8% |
| Accounts receivable | $83.70M | $89.66M | $85.46M | $84.69M | $94.61M | -6.6% |
| Total current assets | $386.98M | $328.37M | $316.92M | $381.19M | $373.30M | +17.8% |
| Property, plant & equipment | $4.54M | — | — | — | — | — |
| Total assets | $2.96B | $2.89B | $2.80B | $2.69B | $2.70B | +2.6% |
| Total current liabilities | $533.95M | $396.66M | $297.17M | $182.50M | $457.83M | +34.6% |
| Current debt | $438.00M | $309.00M | $204.00M | $100.00M | $378.00M | +41.7% |
| Long-term debt | $836.52M | $960.67M | $959.81M | $1.01B | $740.84M | -12.9% |
| Total debt | $1.28B | $1.27B | $1.16B | $1.11B | $1.12B | +0.7% |
| Total liabilities | $1.37B | $1.36B | $1.26B | $1.19B | $1.20B | +1.3% |
| Retained earnings | $2.84B | $2.79B | $2.75B | $2.71B | $2.68B | +2.0% |
| Shareholder equity | $1.57B | $1.51B | $1.52B | $1.48B | $1.48B | +3.7% |
| Working capital | -$146.97M | -$68.29M | $19.75M | $198.69M | -$84.53M | -115.2% |
| Net tangible assets | $1.57B | $1.51B | $1.52B | $1.48B | $1.48B | +3.7% |
| Shares issued | 49.12M | 48.46M | 48.30M | 47.64M | 47.47M | +1.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $55.36M | $39.75M | $37.80M | $32.48M | $36.69M | +39.3% |
| Depreciation & amortisation | $25.55M | $23.69M | $21.65M | $20.22M | $19.92M | +7.8% |
| Stock-based compensation | $2.36M | $2.24M | $964.00K | $983.00K | $1.07M | +5.4% |
| Change in working capital | $2.37M | -$10.13M | $11.76M | -$1.21M | $5.16M | +123.4% |
| Operating cash flow | $64.97M | $53.44M | $67.74M | $62.53M | $59.82M | +21.6% |
| Investing cash flow | -$43.41M | -$103.89M | -$187.03M | $41.67M | -$48.32M | +58.2% |
| Dividends paid | -$44.58M | -$44.44M | -$43.83M | -$42.73M | -$42.02M | -0.3% |
| Financing cash flow | $3.93M | $55.77M | $57.29M | -$41.90M | -$129.46M | -93.0% |
| Free cash flow | $64.97M | $53.44M | $67.74M | $62.53M | $59.82M | +21.6% |
| End cash position | $50.43M | $24.95M | $19.62M | $81.63M | $19.32M | +102.2% |
Options analytics
Put / call volume
1.33
Put-heavy session
Put / call open interest
0.63
Positioning, not flow
Max pain
85.00
+29.7% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
21
Contracts, this expiry
Put volume
28
Contracts, this expiry
Heaviest call OI
95.00
6 contracts
Heaviest put OI
80.00
2 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 4.57 | 1.15 | -74.8% |
| Mar 2026 | 0.86 | 0.77 | -10.5% |
| Dec 2025 | 0.80 | 0.76 | -5.2% |
| Sep 2025 | 0.60 | 0.69 | +14.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 4.56 | 1 | $109.80M | +22.2% |
| Next quarter | 2.67 | 2 | $112.78M | +6.6% |
| Current year | 14.55 | 1 | $456.49M | +21.5% |
| Next year | 3.25 | 3 | $477.01M | +4.5% |
Analyst targets & ownership
Mean target$81.88
High target$90.00
Low target$73.00
Implied upside24.92%
Analyst count8
ConsensusBUY
Strong buy / Buy0 / 5
Hold3
Sell / Strong sell0 / 0
Held by insiders2.39%
Held by institutions79.61%
Institutions holding440
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
66.18
-0.96% from price
SMA 20
67.63
-3.09% from price
SMA 50
71.18
-7.92% from price
SMA 100
73.13
-10.38% from price
SMA 200
77.42
-15.34% from price
EMA 12
66.49
-1.43% from price
EMA 26
68.25
-3.97% from price
EMA 50
70.35
-6.84% from price
RSI (14)
31.3
Neutral
MACD (12,26,9)
-1.75
Hist -0.06
ATR (14)
1.21
1.85% of price
Realised vol 30D
15.3%
Annualised
Bollinger upper
71.14
20, 2σ
Bollinger lower
64.12
20, 2σ
50 / 200 cross
Death
71.18 vs 77.42
Trend bias
Below 200
-15.34%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.28
Less volatile than market
Correlation to SPY
-0.15
Largely independent
Realised vol 30D
15.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-28.6%
Peak to trough
Max drawdown 5Y
-28.6%
Peak to trough
ATR 14
1.21
1.85% of price
Beta (reported)
0.52
5Y monthly, from filing
Short interest
Shares short
2.01M
Prior 2.17M
Change vs prior
-7.6%
Shorts covering
% of float
4.19%
Normal
% of shares out
4.09%
Against total outstanding
Days to cover
6.5
Crowded exit
Float
47.94M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 2, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Sep 1, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jun 25, 26 | Deutsche Bank | MAINTAINED | Hold | Hold |
| Jun 15, 26 | BMO Capital | MAINTAINED | Outperform | Outperform |
| Jun 12, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jun 1, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Apr 22, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Apr 22, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Apr 22, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Mar 27, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Mar 12, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Dec 16, 25 | Truist Securities | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate$3.76 / yr
Forward yield5.74%
5-year avg yield5.58%
Payout ratio106.36%
Ex-dividend dateSep 30, 2026
Next pay dateNov 6, 2026
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-27
Corporate Changes & Voting Matters
8-K · 2026-08-10
Corporate Changes & Voting Matters
8-K · 2026-07-27
Corporate Changes & Voting Matters
8-K · 2026-07-01
Corporate Changes & Voting Matters
8-K · 2026-06-01
Corporate Changes & Voting Matters
8-K · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-04
Corporate Changes & Voting Matters
8-K · 2026-04-23
Headlines
National Health Investors Invests $107.7 Million to Acquire Six Properties in the US
MT Newswires · 6d ago
NHI Announces $107.7 Million SHOP Investment
PR Newswire · 6d ago
The Senior Housing Boom Is Here. These 5 REITs Are Paying Investors to Ride It
24/7 Wall St. · 7d ago
National Health Investors (NHI) Heads To BofA Conference On An Undervalued Senior Housing Narrative
Simply Wall St. · 12d ago
BXP vs. NHI: Which Stock Is the Better Value Option?
Zacks · 13d ago
NHI to Participate in the BofA Securities 2026 Global Real Estate Conference; Updates Pipeline
PR Newswire · 22d ago
Huntington Initiates National Health Investors at Outperform With $79 Price Target
MT Newswires · 27d ago
Truist Trims Price Target on National Health Investors to $80 From $81, Keeps Buy Rating
MT Newswires · 35d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.